Table 1.

Baseline characteristics of analyzed study subjects (N=36) and those lost to follow up before receiving L-DOPA.

Characteristic	Received L-DOPA (N=36)	Did not receive L-DOPA (N=11)
	Mean ± SD	Mean ± SD	p
Age (years)	75.3 ± 7.5	72.1 ± 6.6	0.21
Gender (N male)	16 (44.4%)	2 (18.1%)	0.12
Ethnicity (N Hispanic)	7 (19.4%)	2 (18.1%)	0.93
Race			0.53
Asian	1 (2.8%)	0
Black	14 (38.9%)	3 (27.3%)
White	18 (50.0%)	8 (72.7%)
Other	3 (8.3%)
Diagnosis			0.46
Major Depressive Disorder	21 (58.3%)	8 (72.7%)
Dysthymia	2 (5.6%)	1 (9.1%)
Depression NOS	13 (36.1%)	2 (18.2%)
Duration of current depressive episode (weeks)	528.9 ± 854.6	702.4 ± 1040.4	0.60
Number of prior antidepressant medications	1.4 ± 2.2	1.2 ± 1.3	0.77
Hamilton Rating Scale for Depression (24 item)	15.5 ± 6.0	19.4 ± 4.2	0.056
Inventory of Depressive	26.4 ± 12.6	30.5 ± 12.4	0.47
Symptomatology—Self Report
Clinical Global Impressions—Severity	3.3 ± 0.7	3.7 ± 0.8	0.11
Center for Epidemiologic Studies—Depression	22.5 ± 10.0	24.9 ± 8.7	0.47